293 related articles for article (PubMed ID: 8075890)
1. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus.
Passani MB; Pugliese AM; Azzurrini M; Corradetti R
Br J Pharmacol; 1994 Jun; 112(2):695-703. PubMed ID: 8075890
[TBL] [Abstract][Full Text] [Related]
2. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices.
Pugliese AM; Passani MB; Corradetti R
Br J Pharmacol; 1998 May; 124(1):93-100. PubMed ID: 9630348
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
Waikar MV; Hegde SS; Ford AP; Clarke DE
J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
[TBL] [Abstract][Full Text] [Related]
4. Antagonists of 5-HT4 receptor-mediated responses in adult hippocampal neurons.
Torres GE; Holt IL; Andrade R
J Pharmacol Exp Ther; 1994 Oct; 271(1):255-61. PubMed ID: 7965722
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-HT1A and 5-HT4 receptor agonists on slow synaptic potentials in enteric neurons.
Pan H; Galligan JJ
Eur J Pharmacol; 1995 May; 278(1):67-74. PubMed ID: 7664814
[TBL] [Abstract][Full Text] [Related]
6. Effects on general behaviour and neurotransmitter functions of a new 5-hydroxytryptamine3 receptor antagonist with potential therapeutic relevance in central nervous system disturbances.
Rizzi CA; Prudentino A; Giraldo E
Arzneimittelforschung; 1993 Oct; 43(10):1033-41. PubMed ID: 7903536
[TBL] [Abstract][Full Text] [Related]
7. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
Tokarski K; Bijak M
Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
[TBL] [Abstract][Full Text] [Related]
9. The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs.
Van Meel JC; Diederen W; Haigh R; Wienen W; Pairet M; Turconi M; Doods HN
Eur J Pharmacol; 1993 Mar; 233(2-3):295-7. PubMed ID: 8467876
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum.
McLean PG; Coupar IM; Molenaar P
Br J Pharmacol; 1995 May; 115(1):47-56. PubMed ID: 7647983
[TBL] [Abstract][Full Text] [Related]
11. Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception.
Khasabov SG; Lopez-Garcia JA; Asghar AU; King AE
Br J Pharmacol; 1999 Jun; 127(4):843-52. PubMed ID: 10433490
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices.
Kagami Y; Shigenobu S; Watanabe S
Eur J Pharmacol; 1992 Nov; 224(1):51-6. PubMed ID: 1451743
[TBL] [Abstract][Full Text] [Related]
13. The effect of 5-HT and selective 5-HT receptor agonists and antagonists on rat dorsal vagal preganglionic neurones in vitro.
Albert AP; Spyer KM; Brooks PA
Br J Pharmacol; 1996 Oct; 119(3):519-26. PubMed ID: 8894172
[TBL] [Abstract][Full Text] [Related]
14. Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130.
Yakushiji T; Akaike N
Br J Pharmacol; 1992 Nov; 107(3):853-7. PubMed ID: 1472977
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area.
Prisco S; Pessia M; Ceci A; Borsini F; Esposito E
Eur J Pharmacol; 1992 Apr; 214(1):13-9. PubMed ID: 1582449
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.
Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S
Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198
[TBL] [Abstract][Full Text] [Related]
17. Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain.
Haddjeri N; Blier P
Synapse; 1995 May; 20(1):54-67. PubMed ID: 7624830
[TBL] [Abstract][Full Text] [Related]
18. Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist.
Invernizzi R; Pozzi L; Samanin R
Neuropharmacology; 1995 Feb; 34(2):211-5. PubMed ID: 7617146
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.
Andrade R; Nicoll RA
J Physiol; 1987 Dec; 394():99-124. PubMed ID: 3443977
[TBL] [Abstract][Full Text] [Related]
20. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
